Proceeding contribution from Richard Taylor (Independent (affiliation)) in the House of Commons on Tuesday, 4 November 2008. It occurred during Ministerial statement on NHS Patients (Access to Medicines).
NHS Patients (Access to Medicines)
I have not read the report, and I regret that I am now rather more confused than I was. I still cannot see a fair way of allowing extra payments from those who can afford them. To avoid the need for that, will the Secretary of State revisit better care, better value indicators, which alone would save the NHS £2 billion per year? That could be added to the money available to NICE so that it could pass many more drugs.
Secondary information
- Type
- Proceeding contribution
- Reference
- 482 c144
- Session
- 2007-08
- Chamber / Committee
- House of Commons chamber
- Subjects
- Access Finance Fees and charges Drugs Private sector NHS Medical treatments Patients Payments National Institute for Health and Care Excellence Consequences of Additional Private Drugs for NHS Care Review
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 01:25:59 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_505635
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_505635
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_505635